A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
type: MedicalStudy
description: Treatment Success in Patients Requiring Treatment Change From Olanzapine to Risperidone Long Acting Injectable (TRESOR)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2005-03
end date: 2007-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00216632
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Janssen Pharmaceutica N.V., Belgium
study subject: Schizophrenia
study subject: Psychotic Disorders
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Schizophrenia
keywords: Psychotic Disorders

AI Analytics
type: Organization